Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-25T07:13:12.296Z Has data issue: false hasContentIssue false

The usability and reliability of a smartphone application for monitoring future dementia risk in ageing UK adults

Published online by Cambridge University Press:  15 February 2024

Graham Reid
Affiliation:
Department of Psychiatry, University of Oxford, UK
Philip Vassilev
Affiliation:
Five Lives SAS, Tours, France
Jessica Irving
Affiliation:
Five Lives SAS, Tours, France
Triin Ojakäär
Affiliation:
Five Lives SAS, Tours, France; and Nuffield Department of Clinical Neurosciences, University of Oxford, UK
Liron Jacobson
Affiliation:
Five Lives SAS, Tours, France
Erin G. Lawrence
Affiliation:
Five Lives SAS, Tours, France; and Wolfson Institute of Population Health, Queen Mary University of London, UK
Jenny Barnett
Affiliation:
Five Lives SAS, Tours, France; and Department of Psychiatry, University of Cambridge, UK
Malika Tapparel
Affiliation:
Five Lives SAS, Tours, France; and Department of Medicine, University of Fribourg, Switzerland
Ivan Koychev*
Affiliation:
Department of Psychiatry, University of Oxford, UK; and Five Lives SAS, Tours, France
*
Correspondence: Ivan Koychev. Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Background

The rising number of dementia diagnoses and imminent adoption of disease-modifying treatments necessitate innovative approaches to identify individuals at risk, monitor disease course and intervene non-pharmacologically earlier in the disease course. Digital assessments of dementia risk and cognitive function have the potential to outperform traditional in-person assessments in terms of their affordability, accuracy and longitudinal tracking abilities. However, their accessibility and reliability in older adults is unclear.

Aims

To evaluate the usability and reliability of a smartphone assessment of lifestyle and cognitive factors relevant to dementia risk in a group of UK-based older adults.

Method

Cognitively healthy adults (n = 756) recruited through the Dementias Platform UK Great Minds volunteer register completed three assessments of cognitive function and dementia risk over a 3-month period and provided usability feedback on the Five Lives smartphone application (app). We evaluated cognitive test scores for age, gender and higher education effects, normality distributions, test–retest reliability and their relationship with participants’ lifestyle dementia risk factors.

Results

Participants found the app ‘easy to use’, ‘quick to complete’ and ‘enjoyable’. The cognitive tests showed normal or near-to-normal distributions, variable test–retest reliabilities and age-related effects. Only tests of verbal ability showed gender and education effects. The cognitive tests did not correlate with lifestyle dementia risk scores.

Conclusions

The Five Lives assessment demonstrates high usability and reliability among older adults. These findings highlight the potential of digital assessments in dementia research and clinical practice, enabling improved accessibility and better monitoring of cognitive health on a larger scale than traditional in-person assessments.

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © The Author(s), 2024. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

Dementia represents a significant global health challenge, with implications for individuals, families and healthcare systems. The rising prevalence of the condition, however, has recently been countered by the imminent prospect of disease-modifying therapies entering clinical practice (i.e. amyloid clearance immunotherapies).Reference Guo and Vaishnavi1 That said, these therapies carry a significant risk of side-effects and can be prohibitively expensive. For instance, 1 in 10 clinical trial participants develop cerebral oedema or brain haemorrhage while taking lecanemab,Reference Swanson, Zhang, Dhadda, Wang, Kaplow and Lai2 which has now been approved by the US Food and Drug Administration. Health economic analyses conducted in the European Union indicate that if lecanemab were given to all eligible individuals, its cost alone would account for half of the Union's current medication budget.Reference Jönsson, Wimo, Handels, Johansson, Boada and Engelborghs3 The high costs of both dementia care and its therapies highlight the need to emphasise both early detection and non-pharmacological approaches to reducing disease burden in its preclinical and prodromal stages. This shift in focus requires sensitive and scalable means of identifying dementia risk.

The preclinical window of opportunity

The nature of dementia pathogenesis makes the condition a suitable target for interventions geared at primary and secondary prevention. Risk factors for dementia accumulate across the lifespan, and include genetic predispositions, medical conditions and environmental exposures. Twelve modifiable factors have been found to contribute to up to 40% of worldwide dementia cases.Reference Livingston, Huntley, Sommerlad, Ames, Ballard and Banerjee4 For example, early-life factors such as low educational level may set the stage for increased susceptibility to dementia later in life. As individuals age, additional factors, such as cardiovascular disease, diabetes and sedentary lifestyle, can further compound risk.Reference Wang, Reid, Mackay, Hayes, Bulte and Suri5 Furthermore, dementia pathology tends to emerge decades before a formal clinical diagnosis.Reference Vermunt, Sikkes, van den Hout, Handels, Bos and van der Flier6 This extended pre-symptomatic period provides a crucial window of opportunity for secondary dementia prevention, enabling the identification of high-risk individuals for early intervention before disease onset. However, the current healthcare system is under-resourced and ill-equipped to perform large-scale dementia risk screening or intervention, given the increasing number of cases and the difficulty in identifying individuals in early stages of the disease. Dementia risk factors are also often complex and interrelated, necessitating a comprehensive assessment to accurately evaluate an individual's risk profile, which is resource-intensive and challenging to implement without technology that can track multiple and interacting risk factors over time.Reference Sarah, Michael Ben, Graham, Gregory, Karen and Tam7

Digital healthcare technologies, particularly smartphone applications (apps), may overcome some of the barriers associated with traditional in-person dementia assessments.Reference Chinner, Blane, Lancaster, Hinds and Koychev8,Reference Muurling, de Boer, Kozak, Religa, Koychev and Verheij9 These digital technologies offer some advantages over traditional methods. In the preclinical stages of dementia, cognitive decline often occurs gradually, and early symptoms may be subtle.Reference Kirsty, Jennifer, Jessica, Sarah-Naomi, Thomas and Christopher10 Regular monitoring, facilitated by longitudinal digital healthcare technologies, may therefore become essential for detecting subtle cognitive changes indicating early signs of dementia. By leveraging advanced technologies, these digital assessments could effectively track and identify preclinical individuals in ways that surpass conventional methods employed by clinicians.Reference Staffaroni, Tsoy, Taylor, Boxer and Possin11 This capability has the potential to enhance earlier detection and intervention, which are crucial for effective management of the global burden of the disease.

Validated assessment tools

To maximise the effectiveness of remote digital assessments for dementia risk prevention, it is crucial that they are feasible and use validated and reliable tools that measure constructs with demonstrable relevance to dementia risk.Reference Tsoy, Zygouris and Possin12 Promising cognitive markers of early dementia risk include assessments of verbal fluency, verbal and visual episodic memory, executive function and processing speed. For instance, studies have shown that individuals with very mild dementia due to Alzheimer's disease tend to generate fewer words and word clusters compared with healthy older adults.Reference Gomez and White13 Poorer performance on both verbal and visual memory tests has also been found to predict future dementia up to 10 years before a formal diagnosis.Reference Grober, Lipton, Hall and Crystal14,Reference Kawas, Corrada, Brookmeyer, Morrison, Resnick and Zonderman15 Additionally, executive functioning seems to strongly discriminate healthy individuals from those in early stages of Alzheimer's disease in which deficits in inhibition tend to outperform other cognitive domains in discriminability metrics.Reference Guarino, Favieri, Boncompagni, Agostini, Cantone and Casagrande16,Reference Hutchison, Balota and Duchek17 And last, although domain-specific testing is important, evidence also suggests that a general measure of processing speed is a useful indicator of possible neurodegeneration, as people with suspected dementia show longer response times in tests.Reference Finkel, Reynolds, McArdle and Pedersen18 Together, it should be noted that such composite testing that includes measures of executive function, episodic recall, verbal fluency and processing speed have been noted for their sensitivity in assessing deviations from normal cognition in asymptomatic amyloid-positive individuals, further highlighting their utility in tracking cognitive changes in preclinical individuals.Reference Sperling, Rentz, Johnson, Karlawish, Donohue and Salmon19,Reference Baker, Lim, Pietrzak, Hassenstab, Snyder and Masters20

Enhancing long-term engagement

Beyond the validity of cognitive assessments, the ultimate success of digital dementia risk assessments will rely on creating user-friendly platforms that cater to older adults with varying levels of technological proficiency. The ideal assessment requires minimal supervision, can be completed remotely and provides clear instructions and intuitive interfaces, which maximise user engagement for repeat assessments and continuous monitoring. In doing so, remote dementia assessments may become mainstream tools not only for tracking cognitive changes and identifying individuals at risk for dementia, but potentially even for evaluating the effectiveness of emerging dementia treatments. In the present study, we aimed to assess the usability and reliability of a smartphone app in older adults developed by Five Lives in collaboration with Dementias Platform UK (DPUK) at the University of Oxford.

Method

Participants

The study recruited 756 participants aged between 50 and 79, through the DPUK Great Minds volunteers register.Reference Koychev, Young, Holve, Ben Yehuda and Gallacher21 Participants had to be fluent English speakers and have no reported diagnosis of dementia or mild cognitive impairment. The only exclusion criterion was the lack of access to a suitable mobile device. Participants were approached based on their performance on the Cambridge Neuropsychological Test Automated Battery (CANTAB) Paired Associates Learning (PAL) task (a part of the Great Minds test battery; cambridgecognition.com/) being within 1.5 s.d. of the age-, gender- and education-adjusted mean. The rationale for this stratification was to ensure that this pilot study would gather data from participants with cognitive abilities representative of their age group.

Ethics

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human subjects were approved by North West – Haydock Research Ethics Committee (21/NW/0053). Participants provided written informed consent before any study procedures were carried out.

Materials

The Five Lives risk assessment was delivered through the Five Lives smartphone app (https://www.fivelives.health/app?). The assessment covers four main areas: basic demographic information, self-reported health and lifestyle risk factors for cognitive decline, self-reported memory concerns and five cognitive tests measuring distinct aspects of cognition that are known to measure dementia-related cognitive impairment.

Self-reported health and lifestyle risk factors

A transcript of the full Five Lives questionnaire is available in Supplementary material 1, available at https://dx.doi.org/10.1192/bjp.2024.18. The questionnaire has three modules. ‘About You’ gathers demographic information, including the participant's date of birth, highest level of education, occupational status, height, weight, English proficiency, first-degree relatives with dementia, living area and asks two questions regarding subjective memory concerns. ‘Your Health’ asks questions about the participant's medical conditions known to be relevant to cognitive decline and any medication that they are taking. ‘Your Lifestyle’ asks questions about the participant's diet, exercise, mental activity, sleep, mood, smoking, alcohol consumption and working with toxic materials.Reference Kivipelto, Mangialasche, Snyder, Allegri, Andrieu and Arai22

Cognitive tests

The Five Lives assessment included five tests that measured distinct cognitive domains: semantic and phonemic fluency (‘Snap’), verbal memory (‘Breeze’), visuospatial memory (‘Cast’), executive function (‘Swift’) and speed of processing and cognitive control (‘Twist’) (Table 1). A detailed description of the cognitive tests, as well as representative images of the user interface, can be found in Supplementary material 2.

Table 1 A description of the Five Lives cognitive tests

Procedure

Participants were instructed to download the app on their preferred mobile device (smartphone or tablet) and complete the Five Lives assessment three times: at baseline (assessment 1), 2 weeks later (assessment 2) and 3 months from baseline (assessment 3). Each assessment session required completion of the Five Lives questionnaire and five cognitive tests. The response windows for each assessment lasted for 2 weeks. Reminders to complete the assessment were sent via email on the initial release date and 1 week later. Following assessment 1, participants were asked to complete a short survey online about their experience with the app. Participants were not given a dementia risk result from their assessment answers.

Statistical analyses

Assessment acceptability

Acceptability of the app was quantified as assessment completion rates and time taken to complete each assessment. We also asked participants to complete 10-point Likert scale questionnaires on the app's ease of use, asking ‘How would you rate the app in terms of its ease of use? (1 = very difficult; 10 = very easy)’, the length of the assessment, asking ‘How did you find the length of the assessment? (1 = very long; 10 = very short)’ and the difficulty of the assessment, asking ‘How did you find the difficulty of the assessment? (1 = very difficult; 10 = very easy)’. Open-ended qualitative questions were also included to assess which aspects participants enjoyed and which features they think could be improved.

Test–retest reliability

We calculated the intraclass correlation coefficient (ICC)Reference Koo and Li23 to assess the test–retest reliability of the composite ‘pillar of health’ scores of sleep, physical activity, stress, mental stimulation and diet across the three assessments. Each pillar score was calculated from multiple questions, with a total possible score of 1000. For a full description of the calculations for each pillar, see Supplementary material 3.

Cognitive test performance

Table 1 presents the scoring methodology and outlier handling for each test. Linear regressions were performed to examine the effects of age, gender and having attended college or university on the performance on each cognitive test. Repeated-measures analyses of variance (ANOVAs) were conducted to identify practice effects due to multiple assessments. To avoid false-negative results, thereby overlooking practice effects, we did not apply a family-wise error rate correction. Test–retest reliability between assessments was assessed using ICCs. As participants were drawn from the Great Minds register, they had all undergone previous external testing as part of the CANTAB. Therefore we also correlated participants’ scores on the ‘Cast’ test with their scores on the CANTAB's PAL task, which is considered a gold standard measure of visuospatial memory.Reference Koychev, Young, Holve, Ben Yehuda and Gallacher21,Reference Barnett, Blackwell, Sahakian and Robbins24

Clustering analysis based on lifestyle scores

To classify participants into different lifestyle groups based on their self-reported lifestyle scores, we calculated a composite lifestyle score by averaging the five ‘pillars of health’ scores: diet, physical activity, sleep, mental stimulation and mood. We hypothesised the existence of three clusters, with low, medium and high lifestyle scores. We used hierarchical clustering to analyse lifestyle scores from the three assessments (without averaging across time points) using squared Euclidean distance as the dissimilarity measure. This was done to enhance the interpretability of the results and to avoid a large number of comparisons that would inflate type I error rates. Visual inspection of the dendrogram informed the number of clusters extracted. Missing values were removed. To characterise each of the extracted clusters in terms of lifestyle score, we employed a mixed-effects linear model, with lifestyle score as the dependent variable and assessment time point and lifestyle cluster as the independent variables. We accounted for the repeated measures within each participant. Repeated-measures ANOVAs were used to assess whether participants from different lifestyle clusters performed differently on the five cognitive tests.

Results

Sample demographics

The majority of the study sample were female (67.46%) and the mean age was 65 years (s.d. = 7.9). The mean weight was 75.51 kg (s.d. = 16.27) and the mean height was 167.78 cm (s.d. = 9.11). The largest proportion of participants did not smoke (63.1%), were educated to undergraduate university degree level (36.51%), were retired (66.67%) and lived in rural areas (44.44%). Most participants perceived their memory to be similar to others in their age group (82.67%), but also as being worse than a few years ago (51.72%). For a full description of the participants’ demographics, see Supplementary material 4.

Self-reported risk factors

Participants reported several risk factors for dementia (see Supplementary material 5 for the full results). Among the respondents, 34.43% reported having at least one first-degree relative with dementia, 15.64% reported high blood pressure, 14.84% reported high cholesterol levels, 5.57% reported being diagnosed with diabetes, 1.44% reported having had a stroke, 28.66% reported hearing problems and 43.92% reported visual problems.

Assessment acceptability

Most participants completed the assessments within the required window period of 2 weeks. Assessments 1, 2 and 3 had 95, 92 and 88% completion rates respectively. Overall, 87, 79 and 81% completed assessments 1, 2 and 3 respectively within 24 h or less. The median completion times were 31, 35 and 39 min for assessments 1, 2 and 3 respectively. On a scale of 1 to 10, the Five Lives app was rated as easy to use (mean 8.7, s.d. = 1.6) and participants rated the assessments as short (mean 6.7, s.d. = 1.9) and easy (mean 6.9, s.d. = 1.8) to complete. Qualitative analyses revealed that participants found ‘remembering’ and ‘shapes’ most difficult in the assessment, indicated by a word frequency of 4 and 3% respectively. Participants enjoyed the ‘cognitive’ (2% word frequency) parts of the ‘tests’ (7% word frequency) but indicated that future versions of the app could have better ‘instructions’ (2% word frequency). A fuller summary of responses to the eight Likert-style questions can be found in Supplementary material 6.

Test–retest reliability

Lifestyle questionnaire

Each pillar of health demonstrated substantial to strong reliability, with ICCs of 0.77, 0.79, 0.89, 0.84 and 0.81 for sleep, physical activity, stress, mental stimulation and diet respectively (Supplementary material 7).

Cognitive tests

Good-to-substantial reliability was demonstrated for the semantic and phonemic fluency tests (Snap: 0.75 and 0.71), the executive function test (Swift: 0.78) and the speed of processing and cognitive control test (Twist: 0.60). Moderate reliability was demonstrated for the verbal memory test (Breeze: 0.45 for freely recalled words and 0.40 for the proportion of recalled cued words) and for the visuospatial memory test (Cast: 0.56). Visualisations of the distributions for each test and inter-assessment correlations can be found in Supplementary material 8.

Effect of demographics on cognition

Linear regression analyses found effects of age, gender and education on cognitive testing (Table 2). Although a negative relationship between age and performance was found on all cognitive tests, gender differences were only found for tests measuring verbal memory and verbal fluency. Participants who had completed college or university also performed better on verbal tests. There were no significant effects of gender or higher education for the Cast, Swift or Twist tests.

Table 2 Linear regressions of performance on the Five Lives cognitive tests as a function of age, gender and educational level

**P < 0.01, ***P < 0.001.

Practice effects

ANOVAs revealed a pattern of improved performance after completing each test once (Table 3). Improvements on the Breeze and Cast tests were sustained at the 3-month assessment (P < 0.001). Furthermore, there were statistically significant increases in performance from the 2-week to 3-month assessments for measures of semantic fluency in the Snap test and executive function in the Swift test, and a statistically significant decrease in performance for phonemic fluency in the Snap test (P < 0.001). Additionally, there were improvements in performance from 2 weeks to 3 months on the executive function test (Swift; P < 0.05) and the speed of processing test (Twist; P < 0.005).

Table 3 ANOVA results for practice effects on Five Lives cognitive test performance

*P < 0.05, **P < 0.01, ***P < 0.001.

Validity of visuospatial memory assessments

The number of errors/total rounds completed on the Cast test correlated positively with the adjusted total number of errors on the CANTAB-PAL test (ρ = 0.36, P < 0.001; Supplementary material 9).

Relationship between lifestyle and cognition

Hierarchical clustering analysis

A hierarchical clustering analysis produced a dendrogram with three distinguishable clusters (Supplementary material 10). Across the three assessments, cluster 1 had the highest average lifestyle score, followed by cluster 3 and then cluster 2 (Supplementary material 11). There was a significant main effect of lifestyle cluster, with cluster 2 (β = −314.268, P < 0.001) and cluster 3 (β = −131.643, P < 0.001) showing lower lifestyle scores compared with cluster 1. There was also a significant interaction between the second assessment and cluster 2 (β = −22.777, P = 0.015), and the third assessment and cluster 3 (β = 12.767, P = 0.029), indicating that lifestyle scores in the ‘high’ cluster decreased slightly from the first assessment to the last, whereas lifestyle scores in the ‘medium’ cluster increased in the last assessment relative to the first (Supplementary material 11).

Cluster differences in cognitive performance

ANOVAs showed no significant differences in cognitive performance between lifestyle clusters at the initial and final assessments, except for Breeze scores at the final assessment (Table 4). Nevertheless, subsequent post hoc analyses using the Tukey honestly significant difference (HSD) test on the Breeze scores did not identify any significant differences among the lifestyle clusters. This was likely due to the smaller sample size in the ‘low’ lifestyle score cluster, where only 31 participants completed the Breeze test (compared with n = 121 and n = 179 in the ‘high’ and ‘medium’ clusters respectively).

Table 4 ANOVAs testing the effect of lifestyle cluster on Five Lives cognitive test performance

* P < 0.05.

Discussion

The aim of this study was to assess the usability and reliability of a digital assessment of dementia risk and cognitive function in healthy older adults. The findings revealed that older adults from a research-interested register found the cognitive assessments quick and easy to complete. Cognitive scores showed normal-to-near-normal distributions, with variable reliabilities across different tests. Although cognitive scores did not correlate with participants’ self-reported lifestyle, we found that age had a significant impact on all cognitive tests, but gender and education only influenced tests concerning verbal ability.

This study adds to the existing literature by demonstrating that older adults in our study have positive attitudes towards remote dementia assessments, as evidenced by their favourable ratings of the user experience.Reference Guzman-Parra, Barnestein-Fonseca, Guerrero-Pertiñez, Anderberg, Jimenez-Fernandez and Valero-Moreno25 Furthermore, we expand on previous research that has solely focused on cognitive assessments, by additionally assessing both medical and lifestyle risk factors simultaneously.Reference Öhman, Hassenstab, Berron, Schöll and Papp26 By combining risk factors and cognitive outcomes, our approach surpasses the limitations of isolated assessments and holds the potential for more enhanced risk identification.

Protective and risk factors

Regarding the cognitive tests we used, we found a female and education-related advantage in verbal fluency and verbal episodic memory. These findings align with existing literature showing that females tend to have stable verbal fluency scores between the ages of 40 and 80, whereas males tend to show steeper decline.Reference Maylor, Reimers, Choi, Collaer, Peters and Silverman27,Reference de Frias, Nilsson and Herlitz28 As with verbal fluency, our results also support the existing evidence that females have a slight advantage in verbal recall, as shown in a recent meta-analysis.Reference Voyer, Saint Aubin, Altman and Gallant29 As for education, it has been shown in other studies to predict verbal fluencyReference Mathuranath, George, Cherian, Alexander, Sarma and Sarma30 and verbal memory,Reference Reifegerste, Veríssimo, Rugg, Pullman, Babcock and Glei31 but not visuospatial skills,Reference Berggren, Nilsson and Lövdén32 with limited research on executive function and processing speed. It is possible that the education system's emphasis on language-based instruction and assessment contributes to enhanced verbal abilities, perhaps leading to domain-specific effects of education on older adults’ cognitive abilities.

In contrast to education, we found that age was associated with decreased cognitive performance across all tests, which is consistent with literature suggesting that age is the strongest risk factor for cognitive impairment and dementia. Throughout the lifespan, the accumulation of neurodegenerative risk factors, including brain pathology and cerebrovascular risk factors, affects cognitive abilities in a progressive manner.Reference Stephen, Liu, Ngandu, Rinne, Kemppainen and Parkkola33 Our study found no correlation between participants’ self-reported lifestyle clusters and cognitive abilities, which is to be expected as dementia risk accumulation in the earlier lifespan is likely to affect future cognitive abilities. Although our study collected data on lifestyle and cognition over a 3-month period, tracking lifestyle risk and future cognitive abilities over longer time frames would allow more realistic modelling of the relationship between lifestyle and cognition throughout the lifespan. There are already apps, such as the Cardiovascular Risk Factors, Aging and Incidence of Dementia (CAIDE) Risk Score app, available to model 20-year dementia risk from midlife vascular factors, which form a useful template for future research.Reference Sindi, Calov, Fokkens, Ngandu, Soininen and Tuomilehto34 However, they lack the capability to directly measure cognitive changes, a key feature of our assessment.

Practice effects

As would be expected from existing research, our study showed that multiple testing sessions result in enhanced performance in subsequent cognitive assessments.Reference Alexander, Paul, David and Michael35 Practice effects occur due to increasing familiarity with cognitive tasks and improved strategies developed through repeated testing over time. Initial assessments can be challenging or anxiety-provoking, leading to below-expected performance that regresses to the mean in subsequent tests. Research has shown that modelling practice effects, or the lack thereof, can serve as a useful marker of early cognitive decline since attenuated practice effects have been shown to predict older adults’ progression to Alzheimer's disease, as well as to differentiate those with dementia from healthy age-matched controls.Reference Jutten, Grandoit, Foldi, Sikkes, Jones and Choi36

Distribution of test scores

Just like an individual's ability to learn with practice, the distribution of test scores can also be a useful indicator of cognitive impairment.Reference Kornak, Fields, Kremers, Farmer, Heuer and Forsberg37 Importantly, in our study, cognitive test scores followed normal or near-normal distributions. This suggests that the tests effectively capture the range of cognitive abilities in the population under study and that they have the potential to accurately identify individuals with cognitive impairment. This highlights the utility of digital assessments for tracking dementia risk, as individual scores can be compared with normal distributions to gain relative insight into a participant's cognitive abilities. For instance, standardised scores derived from the normative distributions can identify significant deviations that might indicate cognitive impairment. With a sample of over 700 participants, we have improved on the ability to capture normative scores since previous research has often used much smaller samples.Reference Öhman, Hassenstab, Berron, Schöll and Papp26 By including older adults with diverse educational backgrounds, current health conditions and sociodemographic characteristics, we aimed to avoid skewed or incomplete representations of the population's cognitive abilities, thereby supporting the development of more equitable and inclusive assessment practices.

Limitations

This study has four main limitations to consider. First, our participants were a self-selected group of older adults who were signed up to a research-interested register. These older adults will likely have been more technologically literate than average as they were able to use information technology at the start of the study (e.g. downloading and interacting with a smartphone app). This factor will limit the broader representativeness of the study sample. Additionally, most participants were female, and we did not gather data specifically on participants’ ethnic or socioeconomic backgrounds, aside from educational level. It is well-known that populations engaged in research lack diversity in respect to these characteristics. Considering that factors such as ethnicity, socioeconomic status and gender can influence both dementia risk and ease of using smartphone technology, future studies exploring digital apps in dementia should aim to include a more diverse sample, representing varied genders, ethnicities and socioeconomic backgrounds. Second, standardised testing conditions between participants, and between assessment time points, can be challenging when using remote assessments. Factors such as screen size, device type and environmental distractions may have influenced participants’ responses and performance on cognitive assessments and risk questionnaires. Third, cognitive function and human behaviour are often influenced by the social environment, including social engagement, non-verbal cues and emotions derived from the surroundings. Assessing cognitive abilities in isolation through smartphones may not fully reflect older adults’ true cognitive abilities. This lack of personal context may have influenced the reporting of lifestyle factors, which are typically influenced by social desirability, response bias and expectancy effects when in-person assessments are conducted. Finally, we note that the task completion rates decreased as the study progressed. This highlights the general challenge of user engagement across digital platforms and services. Our participant and public involvement work that led to the study showed that ageing adults say they are more likely to engage with dementia risk assessment if it is linked to treatments. We therefore hypothesise that engagement can be maintained through incorporating such digital risk assessments in treatment pathways – either with behavioural modification strategies to target risk factors or with medications such as the incoming anti-amyloid therapies.

Implications

Despite these limitations, our study demonstrates the potential of smartphone assessments as a tool for remotely tracking dementia risk and cognitive function in a large group of older adults. With the increasing number of dementia cases and the emergence of amyloid-targeting therapies, scalable dementia assessments are needed for risk identification, disease monitoring, treatment outcome tracking and recruitment for clinical trials. In addition, the high cost and risk associated with such therapies should focus efforts on secondary prevention of dementia. Multi-domain prevention programmes aimed at reducing dementia risk face logistical challenges in terms of scalability. Traditional in-person assessments are time-consuming, capacity-limited and resource-intensive. Accessible and reliable screening tools that track individuals over time, such as the smartphone app in this study, can overcome these limitations and offer the potential to alleviate the strain on healthcare systems, allocate resources and funding more efficiently, and identify individuals at the highest risk of dementia.

Supplementary material

Supplementary material is available online at https://doi.org/10.1192/bjp.2024.18.

Data availability

The analytic code associated with this study and the data that support the study findings are available from the corresponding author, G.R., on reasonable request.

Acknowledgement

We acknowledge and thank the participants from Great Minds who contributed to the study.

Author contributions

G.R.: writing – original draft; writing – review and editing; and validation. P.V.: formal analysis; writing – original draft; and writing – review and editing. J.I.: formal analysis; writing – original draft; writing – review and editing. T.O.: formal analysis; writing – review and editing. L.J.: project administration and supervision. E.G.L.: methodology and investigation. J.B.: conceptualisation; methodology; writing – review and editing. M.T.: projection administration and formal analysis. I.K.: Supervision; writing – original draft; writing – review and editing; and project administration.

Funding

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

Declaration of interest

G.R. has received PhD funding from Five Lives. P.V., J.I. and T.O. are employees of Five Lives SAS. L.J., M.T., and E.G.L. are former employees of Five Lives SAS. I.K. is a paid medical advisor for Five Lives SAS; he is also a member of the BJPsych Editorial Board and did not take part in the review or decision-making process of this paper. J.B. is a paid advisor to, and shareholder in, Five Lives SAS.

References

Guo, MH, Vaishnavi, SN. Clinical management in Alzheimer's disease in the era of disease-modifying therapies. Curr Treat Options Neurol 2023; 25: 121–33.10.1007/s11940-023-00750-xCrossRefGoogle Scholar
Swanson, CJ, Zhang, Y, Dhadda, S, Wang, J, Kaplow, J, Lai, RYK, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody. Alz Res Therapy 2021; 13: 80.10.1186/s13195-021-00813-8CrossRefGoogle ScholarPubMed
Jönsson, L, Wimo, A, Handels, R, Johansson, G, Boada, M, Engelborghs, S, et al. The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint. Lancet Reg Health Eur 2023; 29: 100657.10.1016/j.lanepe.2023.100657CrossRefGoogle ScholarPubMed
Livingston, G, Huntley, J, Sommerlad, A, Ames, D, Ballard, C, Banerjee, S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020; 396: 413–46.10.1016/S0140-6736(20)30367-6CrossRefGoogle ScholarPubMed
Wang, C, Reid, G, Mackay, CE, Hayes, G, Bulte, DP, Suri, S. A systematic review of the association between dementia risk factors and cerebrovascular reactivity. Neurosci Biobehav Revi 2023; 148: 105140.10.1016/j.neubiorev.2023.105140CrossRefGoogle ScholarPubMed
Vermunt, L, Sikkes, SAM, van den Hout, A, Handels, R, Bos, I, van der Flier, WM, et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype. Alzheimers Dement 2019; 15: 888–98.10.1016/j.jalz.2019.04.001CrossRefGoogle ScholarPubMed
Sarah, DB, Michael Ben, Y, Graham, R, Gregory, H, Karen, R, Tam, W, et al. Insulin resistance, age and depression's impact on cognition in middle-aged adults from the PREVENT cohort. BMJ Ment Health 2023; 26(1): e300665.Google Scholar
Chinner, A, Blane, J, Lancaster, C, Hinds, C, Koychev, I. Digital technologies for the assessment of cognition: a clinical review. Evid Based Ment Health 2018; 21: 6771.10.1136/eb-2018-102890CrossRefGoogle ScholarPubMed
Muurling, M, de Boer, C, Kozak, R, Religa, D, Koychev, I, Verheij, H, et al. Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study. Alzheimers Res Ther 2021; 13(1): 89.10.1186/s13195-021-00825-4CrossRefGoogle ScholarPubMed
Kirsty, L, Jennifer, MN, Jessica, DC, Sarah-Naomi, J, Thomas, DP, Christopher, AL, et al. Cognition at age 70: life course predictors and associations with brain pathologies. Neurology 2019; 93: e2144–56.Google Scholar
Staffaroni, AM, Tsoy, E, Taylor, J, Boxer, AL, Possin, KL. Digital cognitive assessments for dementia: digital assessments may enhance the efficiency of evaluations in neurology and other clinics. Pract Neurol 2020; 2020: 2445.Google ScholarPubMed
Tsoy, E, Zygouris, S, Possin, KL. Current state of self-administered brief computerized cognitive assessments for detection of cognitive disorders in older adults: a systematic review. J Prev Alzheimers Dis 2021; 8: 267–76.Google ScholarPubMed
Gomez, RG, White, DA. Using verbal fluency to detect very mild dementia of the Alzheimer type. Arch Clin Neuropsychol 2006; 21: 771–5.10.1016/j.acn.2006.06.012CrossRefGoogle ScholarPubMed
Grober, E, Lipton, RB, Hall, C, Crystal, H. Memory impairment on free and cued selective reminding predicts dementia. Neurology 2000; 54: 827–32.10.1212/WNL.54.4.827CrossRefGoogle ScholarPubMed
Kawas, CH, Corrada, MM, Brookmeyer, R, Morrison, A, Resnick, SM, Zonderman, AB, et al. Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology 2003; 60: 1089–93.10.1212/01.WNL.0000055813.36504.BFCrossRefGoogle ScholarPubMed
Guarino, A, Favieri, F, Boncompagni, I, Agostini, F, Cantone, M, Casagrande, M. Executive functions in Alzheimer disease: a systematic review. Front Aging Neurosci 2019; 10: 437.10.3389/fnagi.2018.00437CrossRefGoogle ScholarPubMed
Hutchison, KA, Balota, DA, Duchek, JM. The utility of Stroop task switching as a marker for early-stage Alzheimer's disease. Psychol Aging 2010; 25: 545–59.10.1037/a0018498CrossRefGoogle ScholarPubMed
Finkel, D, Reynolds, CA, McArdle, JJ, Pedersen, NL. Age changes in processing speed as a leading indicator of cognitive aging. Psychol Aging 2007; 22: 558–68.10.1037/0882-7974.22.3.558CrossRefGoogle ScholarPubMed
Sperling, RA, Rentz, DM, Johnson, KA, Karlawish, J, Donohue, M, Salmon, DP, et al. The A4 study: stopping AD before symptoms begin? Sci Transl Med 2014; 6(228): 228fs13.10.1126/scitranslmed.3007941CrossRefGoogle ScholarPubMed
Baker, JE, Lim, YY, Pietrzak, RH, Hassenstab, J, Snyder, PJ, Masters, CL, et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: a meta-analysis. Alzheimer's Dem Diagnosis Assess Dis Monit 2017; 6: 108–21.10.1016/j.dadm.2016.09.002CrossRefGoogle ScholarPubMed
Koychev, I, Young, S, Holve, H, Ben Yehuda, M, Gallacher, J. Dementias platform UK clinical studies and great minds register: protocol of a targeted brain health studies recontact database. BMJ Open 2020; 10(11): e040766.10.1136/bmjopen-2020-040766CrossRefGoogle Scholar
Kivipelto, M, Mangialasche, F, Snyder, HM, Allegri, R, Andrieu, S, Arai, H, et al. World-Wide FINGERS network: a global approach to risk reduction and prevention of dementia. Alzheimers Dement 2020; 16: 1078–94.10.1002/alz.12123CrossRefGoogle ScholarPubMed
Koo, TK, Li, MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016; 15: 155–63.10.1016/j.jcm.2016.02.012CrossRefGoogle ScholarPubMed
Barnett, JH, Blackwell, AD, Sahakian, BJ, Robbins, TW. The paired associates learning (PAL) test: 30 years of CANTAB translational neuroscience from laboratory to bedside in dementia research. Curr Top Behav Neurosci 2016; 28: 449–74.10.1007/7854_2015_5001CrossRefGoogle ScholarPubMed
Guzman-Parra, J, Barnestein-Fonseca, P, Guerrero-Pertiñez, G, Anderberg, P, Jimenez-Fernandez, L, Valero-Moreno, E, et al. Attitudes and use of information and communication technologies in older adults with mild cognitive impairment or early stages of dementia and their caregivers: cross-sectional study. J Med Internet Res 2020; 22(6): e17253.10.2196/17253CrossRefGoogle ScholarPubMed
Öhman, F, Hassenstab, J, Berron, D, Schöll, M, Papp, KV. Current advances in digital cognitive assessment for preclinical Alzheimer's disease. Alzheimers Dement (Amst) 2021; 13(1): e12217.10.1002/dad2.12217CrossRefGoogle ScholarPubMed
Maylor, EA, Reimers, S, Choi, J, Collaer, ML, Peters, M, Silverman, I. Gender and sexual orientation differences in cognition across adulthood: age is kinder to women than to men regardless of sexual orientation. Arch Sex Behav 2007; 36: 235–49.10.1007/s10508-006-9155-yCrossRefGoogle ScholarPubMed
de Frias, CM, Nilsson, L-G, Herlitz, A. Sex differences in cognition are stable over a 10-year period in adulthood and old age. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2006; 13: 574–87.10.1080/13825580600678418CrossRefGoogle Scholar
Voyer, D, Saint Aubin, J, Altman, K, Gallant, G. Sex differences in verbal working memory: a systematic review and meta-analysis. Psychol Bull 2021; 147: 352–98.10.1037/bul0000320CrossRefGoogle ScholarPubMed
Mathuranath, PS, George, A, Cherian, PJ, Alexander, A, Sarma, SG, Sarma, PS. Effects of age, education and gender on verbal fluency. J Clin Exp Neuropsychol 2003; 25: 1057–64.10.1076/jcen.25.8.1057.16736CrossRefGoogle ScholarPubMed
Reifegerste, J, Veríssimo, J, Rugg, MD, Pullman, MY, Babcock, L, Glei, DA, et al. Early-life education may help bolster declarative memory in old age, especially for women. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2021; 28: 218–52.10.1080/13825585.2020.1736497CrossRefGoogle ScholarPubMed
Berggren, R, Nilsson, J, Lövdén, M. Education does not affect cognitive decline in aging: a Bayesian assessment of the association between education and change in cognitive performance. Front Psychol 2018; 9: 1138.10.3389/fpsyg.2018.01138CrossRefGoogle Scholar
Stephen, R, Liu, Y, Ngandu, T, Rinne, JO, Kemppainen, N, Parkkola, R, et al. Associations of CAIDE dementia risk score with MRI, PIB-PET measures, and cognition. J Alzheimer's Dis 2017; 59: 695705.10.3233/JAD-170092CrossRefGoogle ScholarPubMed
Sindi, S, Calov, E, Fokkens, J, Ngandu, T, Soininen, H, Tuomilehto, J, et al. The CAIDE dementia risk score app: the development of an evidence-based mobile application to predict the risk of dementia. Alzheimers Dement (Amst) 2015; 1: 328–33.10.1016/j.dadm.2015.06.005CrossRefGoogle ScholarPubMed
Alexander, C, Paul, M, David, GD, Michael, M. The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test–retest intervals. J Int Neuropsychol Soc 2003; 9: 419–28.Google Scholar
Jutten, RJ, Grandoit, E, Foldi, NS, Sikkes, SAM, Jones, RN, Choi, SE, et al. Lower practice effects as a marker of cognitive performance and dementia risk: a literature review. Alzheimers Dement (Amst) 2020; 12(1): e12055.Google ScholarPubMed
Kornak, J, Fields, J, Kremers, W, Farmer, S, Heuer, HW, Forsberg, L, et al. Nonlinear Z-score modeling for improved detection of cognitive abnormality. Alzheimer's Dem Diagnosis Assess Dis Monit 2019; 11: 797808.10.1016/j.dadm.2019.08.003CrossRefGoogle ScholarPubMed
Figure 0

Table 1 A description of the Five Lives cognitive tests

Figure 1

Table 2 Linear regressions of performance on the Five Lives cognitive tests as a function of age, gender and educational level

Figure 2

Table 3 ANOVA results for practice effects on Five Lives cognitive test performance

Figure 3

Table 4 ANOVAs testing the effect of lifestyle cluster on Five Lives cognitive test performance

Supplementary material: File

Reid et al. supplementary material 1

Reid et al. supplementary material
Download Reid et al. supplementary material 1(File)
File 35 KB
Supplementary material: File

Reid et al. supplementary material 2

Reid et al. supplementary material
Download Reid et al. supplementary material 2(File)
File 148.6 KB
Supplementary material: File

Reid et al. supplementary material 3

Reid et al. supplementary material
Download Reid et al. supplementary material 3(File)
File 107.3 KB
Supplementary material: File

Reid et al. supplementary material 4

Reid et al. supplementary material
Download Reid et al. supplementary material 4(File)
File 604.1 KB
Supplementary material: File

Reid et al. supplementary material 5

Reid et al. supplementary material
Download Reid et al. supplementary material 5(File)
File 14.7 KB
Supplementary material: File

Reid et al. supplementary material 6

Reid et al. supplementary material
Download Reid et al. supplementary material 6(File)
File 17.1 KB
Supplementary material: File

Reid et al. supplementary material 7

Reid et al. supplementary material
Download Reid et al. supplementary material 7(File)
File 19.4 KB
Supplementary material: File

Reid et al. supplementary material 8

Reid et al. supplementary material
Download Reid et al. supplementary material 8(File)
File 784.2 KB
Supplementary material: File

Reid et al. supplementary material 9

Reid et al. supplementary material
Download Reid et al. supplementary material 9(File)
File 3.5 MB
Supplementary material: File

Reid et al. supplementary material 10

Reid et al. supplementary material
Download Reid et al. supplementary material 10(File)
File 6.2 MB
Supplementary material: File

Reid et al. supplementary material 11

Reid et al. supplementary material
Download Reid et al. supplementary material 11(File)
File 53.6 KB
Submit a response

eLetters

No eLetters have been published for this article.